Futibatinib is a medicine that inhibits FGFR, helping to treat cholangiocarcinoma with FGFR2 fusions. It blocks the FGFR signaling. The tablets are 4 mg each and you take them once a day, with a suggested dose of 20 mg.
Each pack has 28 tablets. The tablets are a controlled way to take the medicine, with the right amount already measured out, so you don’t have to worry about dosing mistakes. A bottle with 28 tablets is enough for a month’s worth of the recommended dose, making it easy and cost-effective for both patients and healthcare folks.
Reviews
There are no reviews yet.